| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/27/1995 | WO1995011244A1 Pyridazino quinoline compounds |
| 04/27/1995 | WO1995011242A1 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
| 04/27/1995 | WO1995011240A1 Amine derivatives as calcium channel antagonists |
| 04/27/1995 | WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011221A1 Calcium receptor-active arylalkyl amines |
| 04/27/1995 | WO1995011031A1 Cerebral metabolism activator containing glucose ester derivative |
| 04/27/1995 | WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | WO1995011014A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011006A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
| 04/27/1995 | WO1994027594A3 Stable copper(i) complexes and methods related thereto |
| 04/27/1995 | CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2173366A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
| 04/27/1995 | CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | CA2171332A1 Pyridazino quinoline compounds |
| 04/27/1995 | CA2170735A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2152357A1 Cerebral metabolism activator containing glucose ester derivative |
| 04/26/1995 | EP0649907A1 Enzymatic hydroxylation process for the preparation of HMG-COA reductase inhibitors and intermediates thereof |
| 04/26/1995 | EP0649654A1 Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649411A1 Boronated compounds |
| 04/26/1995 | EP0649409A1 Vinyl arenas having retinoid-like activity |
| 04/26/1995 | EP0649405A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs. |
| 04/26/1995 | EP0537300B1 Oxazolidinedione hypoglycemic and hypocholesterolemic agents |
| 04/26/1995 | EP0533724B1 Calcium citrate malate composition |
| 04/26/1995 | EP0505468B1 Imidazole derivatives and their use as acyl coenzyme-a inhibitors |
| 04/26/1995 | CN1102040A Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
| 04/26/1995 | CN1101911A Novel compounds |
| 04/25/1995 | US5409950 Anticholesterol, antilipemic agents and an enzyme squalene synthase inhibitors, fungicides |
| 04/25/1995 | US5409911 Prostaglandin analog for treating osteoporosis |
| 04/25/1995 | US5409910 Treating hyperlipoproteinemia and arteriosclerosis |
| 04/25/1995 | US5409899 Pseudopeptide compounds having anti-inflammatory activity |
| 04/25/1995 | CA1335379C Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/25/1995 | CA1335378C Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/25/1995 | CA1335375C Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical composition containing them |
| 04/23/1995 | CA2134025A1 Enzymatic hydroxylation process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010513A1 Benzothiophenes and related compounds as estrogen agonists |
| 04/20/1995 | WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | CA2173243A1 Benzothiophenes and related compounds as estrogen agonists |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/19/1995 | EP0648495A2 Cation-complexed polysaccharides |
| 04/19/1995 | EP0648490A2 Septicemia suppressing substitution fluid preparation |
| 04/19/1995 | EP0648212A1 Heterocyclic compounds as pharmaceutical |
| 04/19/1995 | EP0648206A1 Peptidyl derivatives and their use as metalloproteinase inhibitors |
| 04/19/1995 | EP0648120A1 Use of phosphonates for the treatment of osteoporosis |
| 04/19/1995 | EP0648108A1 Prophylactic and therapeutical preparation against caries. |
| 04/19/1995 | EP0510036B1 2-substituted 4,5-diphenyl-imidazoles |
| 04/19/1995 | EP0497915B1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/19/1995 | EP0468042B1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1alpha-HYDROXYLATED DERIVATIVES |
| 04/19/1995 | CN1028237C Composition for stimulating chondrocytes and osteoblasts, method for its production |
| 04/18/1995 | US5408041 Multiple elutions with Sepharose, Sephacryl, HPLC; for bone disorders, osteoporosis, Paget*s disease |
| 04/18/1995 | US5407957 Production of docosahexaenoic acid by dinoflagellates |
| 04/18/1995 | US5407955 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| 04/18/1995 | US5407951 Sulphonamidocycloalkane compounds, pharmaceutical compositions containing them, and methods of use thereof |
| 04/18/1995 | US5407812 Crystalline 2-O-α-D-glucopyranosyl-L-ascorbic acid, and its preparation and uses |
| 04/18/1995 | US5407677 Containing fennel extract, inositol, dextran sulfate |
| 04/18/1995 | CA1335261C Fine-milled colestipol hydrochloride |
| 04/16/1995 | CA2117853A1 Methods for lowering serum cholesterol |
| 04/13/1995 | WO1995009619A2 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 04/12/1995 | EP0647636A1 Benzothiazole compound, process for producing the same, and use thereof |
| 04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
| 04/12/1995 | EP0647236A1 Endothelin antagonists ii |
| 04/12/1995 | EP0647234A1 Steroidal glycosides for treating hypercholesterolemia |
| 04/12/1995 | EP0647219A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs. |
| 04/12/1995 | EP0647145A1 Storing stable bicarbonate solutions |
| 04/12/1995 | EP0647134A1 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
| 04/12/1995 | EP0647131A1 Dermatological agent for aiding oxygen transport in the skin. |
| 04/12/1995 | EP0568546B1 Bridged cyclic ketal derivatives |
| 04/12/1995 | EP0428668B1 Water-soluble vitamin a preparations for application to the skin |
| 04/12/1995 | CN1101349A Novel compounds |
| 04/12/1995 | CN1101262A Antidiabetic agent |
| 04/11/1995 | US5405994 Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present |
| 04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
| 04/06/1995 | WO1995009231A1 Insulin-secreting cell lines, methods of production and use |
| 04/06/1995 | WO1995008995A1 Antiobestic agent |
| 04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 04/06/1995 | CA2172997A1 Insulin-secreting cell lines, methods of production and use |
| 04/05/1995 | EP0646601A1 Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 04/05/1995 | EP0646379A1 Insulin formulation |
| 04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
| 04/05/1995 | EP0646128A1 Glucagon-like peptide and insulinotropin derivatives |
| 04/05/1995 | EP0646126A1 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same |
| 04/05/1995 | EP0646014A1 The use of hyperimmune milk to increase longevity |
| 04/05/1995 | EP0645997A1 Cosmetic containing phospholipids and fluorocarbon compounds. |
| 04/05/1995 | EP0469084B1 Hepatospecific insulin analogues |
| 04/05/1995 | EP0365664B1 Use of synthetic l-carnitine in food for domestic dogs or cats |
| 04/05/1995 | CN1100933A Hypoglycemic agents |
| 04/04/1995 | US5403940 Vitamin D compound, method of preparing this compound and intermediate thereof |
| 04/04/1995 | US5403921 Drinking a solution of glycerol and water two hours before exertion and continuing until one-half hour before starting; phsiological effects |
| 04/04/1995 | US5403834 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/04/1995 | US5403829 Administering to promote formation of bone tissue |
| 04/04/1995 | CA1335105C 1.alpha.-hydroxyvitamin d2 epimer and derivatives |
| 04/04/1995 | CA1335104C Diphenyl-3-azahexane and diphenyl-4-azaheptane derivatives, pharmaceutical compositions containing them and process for their preparation |
| 04/04/1995 | CA1335077C Process for the manufacture of apolipoproteins from human blood plasma or serum |
| 04/04/1995 | CA1335076C Pharmaceutical composition and method for intranasal administration |
| 03/30/1995 | WO1995008547A1 Novel dihispidine derivatives, process for producing them and medicaments containing these compounds |
| 03/30/1995 | WO1995008532A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 03/30/1995 | WO1995008528A1 Triaryl-ethylene derivatives for use in therapy |